
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Head-to-head comparison of available commercial antibodies against Leucine-rich repeat kinase 2 (LRRK2) by immunoblot (Western blot), immunoprecipitation and immunofluorescence. Work reported in this report was supported in part by the Michael J. Fox Foundation for Parkinson's research.
Q5S007, antibody characterization, Leucine-rich repeat serine/threonine-protein kinase 2, Leucine-rich repeat kinase 2, Parkinson's disease, LRRK2, Dardarin, antibody validation
Q5S007, antibody characterization, Leucine-rich repeat serine/threonine-protein kinase 2, Leucine-rich repeat kinase 2, Parkinson's disease, LRRK2, Dardarin, antibody validation
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
views | 81 | |
downloads | 51 |